Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditionsCHAITMAN, Bernard R.Circulation (New York, N.Y.). 2006, Vol 113, Num 20, pp 2462-2472, issn 0009-7322, 11 p.Article

Is ST segment elevation non-Q-wave myocardial infarction after thrombolytic therapy a new clinical entity that requires an invasive management strategy?CHAITMAN, Bernard R; BITAR, Saad R.Journal of the American College of Cardiology. 2001, Vol 37, Num 1, pp 26-29, issn 0735-1097Conference Paper

Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart diseaseCHAITMAN, Bernard R; SANO, Junko.Clinical cardiology. Supplement (Mahwah, NJ). 2007, Vol 30, Num 1, 1.25-1.30Article

Effects of ranolazine on exercise tolerance and HbA_1c in patients with chronic angina and diabetesTIMMIS, Adam D; CHAITMAN, Bernard R; CRAGER, Michael et al.European heart journal. 2006, Vol 27, Num 1, pp 42-48, issn 0195-668X, 7 p.Article

Electrocardiographic changes in intracranial hemorrhage mimicking myocardial infarctionBAILEY, W. Brian; CHAITMAN, Bernard R.The New England journal of medicine. 2003, Vol 349, Num 6, issn 0028-4793, p. 561Article

Electrocardiography Screening for Cardiotoxicity after Modified Vaccinia Ankara VaccinationSANO, Junko; CHAITMAN, Bernard R; SWINDLE, Jason et al.The American journal of medicine. 2009, Vol 122, Num 1, pp 79-84, issn 0002-9343, 6 p.Article

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: A myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) substudyWATERS, David D; SCHWARTZ, Gregory G; OLSSON, Anders G et al.Circulation (New York, N.Y.). 2002, Vol 106, Num 13, pp 1690-1695, issn 0009-7322Article

High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialSCHWARTZ, Gregory G; CHAITMAN, Bernard R; GOLDBERGER, Jeffrey J et al.The American heart journal. 2011, Vol 161, Num 5, pp 993-999, issn 0002-8703, 7 p.Article

Intensive Multifactorial Intervention for Stable Coronary Artery Disease: Optimal Medical Therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial : Prevention/outcomesMARON, David J; BODEN, William E; HARRIS, Crystal L et al.Journal of the American College of Cardiology. 2010, Vol 55, Num 13, pp 1348-1358, issn 0735-1097, 11 p.Article

Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System?CHAITMAN, Bernard R; HARTIGAN, Pamela M; WEINTRAUB, William S et al.Circulation. Cardiovascular quality and outcomes (Print). 2010, Vol 3, Num 5, pp 476-483, issn 1941-7713, 8 p.Article

Efficacy of Ranolazine in Patients With Chronic Angina : Observations From the Randomized, Double-Blind, Placebo-Controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 TrialWILSON, Sean R; SCIRICA, Benjamin M; BRAUNWALD, Eugene et al.Journal of the American College of Cardiology. 2009, Vol 53, Num 17, pp 1510-1516, issn 0735-1097, 7 p.Article

Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) TrialMARON, David J; SPERTUS, John A; CHAITMAN, Bernard R et al.The American journal of cardiology. 2009, Vol 104, Num 8, pp 1055-1062, issn 0002-9149, 8 p.Article

Clinical and research issues regarding chronic advanced coronary artery disease: Part I: Contemporary and emerging therapiesMARC JOLICOEUR, E; GRANGER, Christopher B; HENRY, Timothy D et al.The American heart journal. 2008, Vol 155, Num 3, pp 418-434, issn 0002-8703, 17 p.Article

Anti-ischemic effects and long-term survival during Ranolazine Monotherapy in Patients with chronic severe anginaCHAITMAN, Bernard R; SKETTINO, Sandra L; WOLFF, Andrew A et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 8, pp 1375-1382, issn 0735-1097, 8 p.Article

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes : The MIRACL study : A randomized controlled trialSCHWARTZ, Gregory G; OLSSON, Anders G; EZEKOWITZ, Michael D et al.JAMA, the journal of the American Medical Association. 2001, Vol 285, Num 13, pp 1711-1718, issn 0098-7484Article

False-negative and false-positive ECG diagnoses of Q wave myocardial infarction in the presence of right bundle-branch blockGUSSAK, Ihor; WRIGHT, R. Scott; BJERREGAARD, Preben et al.Cardiology. 2000, Vol 94, Num 3, pp 165-172, issn 0008-6312Article

Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary interventionSHAW, Leslee J; WEINTRAUB, William S; SPERTUS, John A et al.The American heart journal. 2012, Vol 164, Num 2, pp 243-250, issn 0002-8703, 8 p.Article

Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)GOSSELIN, Gilbert; TEO, Koon K; SPERTUS, John A et al.The American journal of cardiology. 2012, Vol 109, Num 7, pp 954-959, issn 0002-9149, 6 p.Article

Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy Observations From the COURAGE TrialJOHN MANCINI, G. B; HARTIGAN, Pamela M; TEO, Koon K et al.Circulation. Cardiovascular interventions. 2011, Vol 4, Num 6, pp 545-552, issn 1941-7640, 8 p.Article

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden : Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear SubstudySHAW, Leslee J; BERMAN, Daniel S; CHAITMAN, Bernard R et al.Circulation (New York, N.Y.). 2008, Vol 117, Num 10, pp 1283-1291, issn 0009-7322, 9 p.Article

Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseasesMARON, Barry J; CHAITMAN, Bernard R; LIANG, David H et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 22, pp 2807-2816, issn 0009-7322, 10 p.Article

Standards for the function of an Academic 12-lead electrocardiographic Core LaboratoryANDERSON, Stanley T; PAHLM, Olle; MACFARLANE, Peter W et al.Journal of electrocardiology. 2001, Vol 34, Num 1, pp 41-47, issn 0022-0736Article

Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes : An advisory for healthcare professionals from the Working Groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and PreventionMARON, Barry J; ARAUJO, Claudio Gil S; ELOSUA, Roberto et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 2, pp 327-334, issn 0009-7322Conference Paper

Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patientsYOKOYAMA, Yasuhiro; CHAITMAN, Bernard R; DETRE, Katherine M et al.The American journal of cardiology. 2000, Vol 86, Num 8, pp 819-824, issn 0002-9149Article

2013 ACCF/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes and Coronary Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)CANNON, Christopher P; BRINDIS, Ralph G; GRAY, Darryl T et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 9, pp 1052-1089, issn 0009-7322, 38 p.Article